PPARs and lipid ligands in inflammation and metabolism

Harmon, Gregory S., Lam, Michael T., Glass, Christopher K.·2011·Chemical Reviews

Cited by (224)

Items 101–200 of 224

  1. Immunometabolic Targets in CD8+ T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma
    Yanze Lin, Rexiati Ruze, Ruiqing Zhang, Talaiti Tuergan, Maolin Wang, Alimu Tulahong, Dalong Zhu, Zhongdian Yuan, Tiemin Jiang, Tuerganaili Aji et al. · 2024 · Liver Cancer
  2. Determination of in vitro immunotoxic potencies of a series of perfluoralkylsubstances (PFASs) in human Namalwa B lymphocyte and human Jurkat T lymphocyte cells
    Aafke W. F. Janssen, Wendy Jansen Holleboom, Deborah Rijkers, Jochem Louisse, Sjoerdtje A. Hoekstra, Sanne Schild, Misha F. Vrolijk, Laurentius A. P. Hoogenboom, Karsten Beekmann · 2024 · Frontiers in Toxicology
  3. A chemoinformatics search for peroxisome proliferator-activated receptors ligands revealed a new pan-agonist able to reduce lipid accumulation and improve insulin sensitivity
    Sabina Sblano, Carmen Cerchia, Antonio Laghezza, Luca Piemontese, Leonardo Brunetti, Rosalba Leuci, Federica Gilardi, Aurélien Thomas, Massimo Genovese, Alice Santi et al. · 2022 · European Journal of Medicinal Chemistry
  4. Gene expression of adipose tissue, endothelial cells and platelets in subjects with metabolic syndrome (Review)
    Iván F. Palomo · 2012 · Molecular Medicine Reports
  5. Larsucosterol: endogenous epigenetic regulator for treating chronic and acute liver diseases
    Yaping Wang, Jenna Ren, Shunlin Ren · 2024 · American Journal of Physiology-Endocrinology and Metabolism
  6. Discovery of Pan-peroxisome Proliferator-Activated Receptor Modulators from an Endolichenic Fungus, Daldinia childiae
    Jaekyeong Kim, Hyejin Ko, Jae–Seoun Hur, Seungchan An, Jin Woo Lee, Stephen T. Deyrup, Minsoo Noh, Sang Hee Shim · 2022 · Journal of Natural Products
  7. The PPARΩPocket: Renewed Opportunities for Drug Development
    Åsmund Kaupang, Trond Vidar Hansen · 2020 · PPAR Research
  8. A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition
    Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Rosalba Leuci, Erica Pranzini, Alice Santi, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas et al. · 2023 · Journal of Medicinal Chemistry
  9. Prenylated Chrysin Derivatives as Partial PPARγ Agonists with Adiponectin Secretion-Inducing Activity
    Seungchan An, Hyejin Ko, Hongjun Jang, In Guk Park, Sungjin Ahn, Seok Young Hwang, Junpyo Gong, Soyeon Oh, Soo Yeon Kwak, Yeonjin Lee et al. · 2023 · ACS Medicinal Chemistry Letters
  10. Neferine alleviates acute kidney injury by regulating the PPAR-α/NF-κB pathway
    Yanying Xiong, Jin Zhong, Wenhang Chen, Xuan Li, Hong Shu Liu, Ying Li, Weijian Xiong, Huihui Li · 2024 · Clinical and Experimental Nephrology
  11. Defective expression of the peroxisome regulators PPARα receptors and lysogenesis with increased cellular senescence in the venous wall of chronic venous disorder.
    Miguel Angel Ortega, Oscar Fraile‐Μartinez, Leonel Pekarek, Miguel Ángel Álvarez-Mon, Ángel Asúnsolo, Lara Sánchez‐Trujillo, Santiago Coca, Julia Buján, Melchor Álvarez‐Mon, Natalio García‐Honduvilla et al. · 2021 · PubMed
  12. Peroxisome Proliferator-activated Receptor-γ As A Novel and Promising Target For Treating Cancer Via Regulation of Inflammation: A Brief Review
    S. Yuvaraj, B. R. Prashantha Kumar · 2021 · Mini-Reviews in Medicinal Chemistry
  13. Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors
    Shivanand Pudakalakatti, Mark Anton Titus, José S. Enriquez, Sumankalai Ramachandran, Niki Marie Zacharias, Imad Shureiqi, Yi Liu, James C. Yao, Xiangsheng Zuo, Pratip K. Bhattacharya · 2022 · International Journal of Molecular Sciences
  14. Exploring Novel Therapeutics for Pulmonary Arterial Hypertension
    Takayuki Fujiwara, Satoshi Ishii, Shun Minatsuki, Masaru Hatano, Norifumi Takeda · 2025 · International Heart Journal
  15. Computational Prediction of the Phenotypic Effect of Flavonoids on Adiponectin Biosynthesis
    Seungchan An, Seok Young Hwang, Junpyo Gong, Sungjin Ahn, In Guk Park, Soyeon Oh, Young‐Won Chin, Minsoo Noh · 2023 · Journal of Chemical Information and Modeling
  16. CES1 Releases Oxylipins from Oxidized Triacylglycerol (oxTAG) and Regulates Macrophage oxTAG/TAG Accumulation and PGE2/IL-1β Production
    Maggie E. Phillips, Oluwabori Adekanye, Abdolsamad Borazjani, John Allen Crow, Matthew K. Ross · 2023 · ACS Chemical Biology
  17. Effect of chiglitazar and sitagliptin on glucose variations, insulin resistance and inflammatory-related biomarkers in untreated patients with type 2 diabetes
    Yuming Wang, Huiqin Li, Hui Gao, Xiaohua Xu, Tingting Cai, Huiying Wang, Yunting Zhou, Rong Huang, Xiaofei Su, Jiahuan Ma · 2021 · Diabetes Research and Clinical Practice
  18. Harnessing conserved signaling and metabolic pathways to enhance the maturation of functional engineered tissues
    Neal I. Callaghan, Lauren J. Durland, Ronald G. Ireland, J. Paul Santerre, Craig A. Simmons, Locke Davenport Huyer · 2022 · npj Regenerative Medicine
  19. Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis
    Gang Sun, Zhiqi Feng, Yufan Kuang, Zhuoxin Fu, Yanyan Wang, Xing Zhao, Fengqin Wang, Hongbin Sun, Haoliang Yuan, Liang Xiang Dai · 2024 · European Journal of Medicinal Chemistry
  20. Synthesis, biological evaluation and molecular modeling studies of the PPARβ/δ antagonist CC618
    Åsmund Kaupang, Steinar Martin Paulsen, Calin Constantin Steindal, Aina Westrheim Ravna, Ingebrigt Sylte, Trine Grønhaug Halvorsen, G. Hege Thoresen, Trond Vidar Hansen · 2015 · European Journal of Medicinal Chemistry
  21. Antidiabetic effect of SN158 through PPARα/γ dual activation in ob/ob mice
    Yujung Jung, Yongkai Cao, Suresh Paudel, Goo Yoon, Seung Hoon Cheon, Gyu‐Un Bae, Li Tai Jin, Yong Kee Kim, Su‐Nam Kim · 2017 · Chemico-Biological Interactions
  22. The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases
    Edit Posta, István Fekete, István Zsolt Várkonyi, Éva Zöld, Zsolt Barta · 2024 · Cells
  23. Bone matrix-mimetic multi-ion doped hydroxyapatite nanorod arrays for enhanced immuno-osteogenesis and prevention of aseptic loosening
    Jing Ye, Bo Li, Meng Ying Yu, Yingang Zhang, Yong Nam Han · 2025 · Bioactive Materials
  24. Proliferation and differentiation of adipose tissue in prolonged lean and obese critically ill patients
    Chloë Goossens, Sarah Vander Perre, Greet Van den Berghe, Lies Langouche · 2017 · Intensive Care Medicine Experimental
  25. Fenofibrate differentially activates PPARα-mediated lipid metabolism in rat kidney and liver
    Venkat Reddy Pannala, Michele R. Balik-Meisner, Deepak Mav, Dhiral P. Phadke, Elizabeth H. Scholl, Ruchir Shah, Warren Casey, Scott S. Auerbach, Anders Wallqvist · 2025 · Scientific Reports
  26. Signaling pathways shaping the field of lipidomics.
    E. P. Ahi, Andrew H. House · 2025 · Prostaglandins & other lipid mediators
  27. SNPs, transcriptional factor binding sites and disease
    Norman E. Buroker · 2017 · Biomedical Genetics and Genomics
  28. Clickable corneal neovascularization therapy with ROS-responsive polydopamine silica nanoparticles loaded with fenofibrate
    Kai Fan, Lixue Yu, Yuehuang Wu, Lan Zheng, Xiuqin Yang, Jingwei Lin, Mengyuan Wang, Yingyue Ye, Ruimiao Lin, Quancheng Chen et al. · 2023 · Materials & Design
  29. Differentially expressed genes in PPARγ-deficient MSCs
    Yun Su, Xiaona Shen, Jie Chen, Carlos M. Isales, Jing Zhao, Xingming Shi · 2017 · Molecular and Cellular Endocrinology
  30. Integrated approaches to unravel the impact of protein lipoxidation on macromolecular interactions
    Silvia Zorrilla, Andreia Mónico, Sofía Duarte, Germán Rivas, Dolores Pérez‐Sala, Marı́a A. Pajares · 2019 · Free Radical Biology and Medicine
  31. EV-Encapsulated Mitochondrial miRNAs: Enhancing Cardiomyocyte Bioenergetics
    Dhienda C. Shahannaz, Tadahisa Sugiura · 2026 · International Journal of Molecular Sciences
  32. IL-33 promotes pancreatic β-cell survival and insulin secretion under diabetogenic conditions through PPARγ
    Jian Lin, Yan Lan, Daochun Xiang, Rui Ma, Qianjiang Chen, Ke Ding, Jingli Lü · 2023 · European Journal of Pharmacology
  33. Qing-Luo-Yin Eased Adjuvant-Induced Arthritis by Inhibiting SIRT1-Controlled Visfatin Production in White Adipose Tissues
    Dandan Wang, Meng-Ke Song, Qin Yin, Wen-Gang Chen, Opeyemi Joshua Olatunji, Kui Yang, Jian Zuo · 2024 · Journal of Inflammation Research
  34. Protective effects of pioglitazone on vascular endothelial cell dysfunction induced by high glucose via inhibition of IKKα/β–NFκB signaling mediated by PPARγ in vitro
    Chunxiang Chen, Shaorong Peng, Fanghui Chen, Lili Liu, Zhou-Xue Li, Guohua Zeng, Qiren Huang · 2017 · Canadian Journal of Physiology and Pharmacology
  35. Unlocking secrets: lipid metabolism and lipid droplet crucial roles in SARS-CoV-2 infection and the immune response
    Vinícius Cardoso Soares, Suelen da Silva Gomes Dias, Julia Cunha Santos, Patrícia Torres Bozza · 2024 · Journal of Leukocyte Biology
  36. Imidazole propionate ameliorates lipid metabolism in adipocytes to attenuate high-fat diet-induced obesity via PPAR signaling pathway
    Caiyu Lin, Zhou Peng, Juan Du, Xiaoyu Shan, Zhongxiao Zhang, Liling Xu, Shan Huang, Jianfang Gao, Xirong Guo · 2025 · Lipids in Health and Disease
  37. A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties
    Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Roberta Montanari, Davide Capelli, Judith Wackerlig, Stefan Simić, Emanuele Falbo, Lucia Pecora, Rosalba Leuci et al. · 2024 · European Journal of Medicinal Chemistry
  38. Utilization of Cannabidiol in Post-Organ-Transplant Care
    幸子 小山, Jumar Etkins, Joshua Jun, Matthew Miller, Gerald C. So, Debora L. Gisch, Michael T. Eadon · 2025 · International Journal of Molecular Sciences
  39. Perfluorooctanoic acid (PFOA) disrupts cardiac performance of thick-shell mussel by inserting into the binding pocket of proliferator-activated receptor gamma and thereby causing lipid metabolism disorders
    Yingying Yu, Kuankuan Yuan, Difei Tong, Weixia Zhang, Weishang Zhou, Weifeng Li, Wei Ming Shi, Wei‐Dong Yang, Xinguo Zhao, Guangxu Liu · 2025 · Environmental Pollution
  40. Galangin 3-benzyl-5-methylether derivatives function as an adiponectin synthesis-promoting peroxisome proliferator-activated receptor γ partial agonist
    Hyejin Ko, Hongjun Jang, Seungchan An, In Guk Park, Sungjin Ahn, Junpyo Gong, Seok Young Hwang, Soyeon Oh, Soo Yeon Kwak, Won Jun Choi et al. · 2021 · Bioorganic & Medicinal Chemistry
  41. Musclin Mitigates the Attachment of HUVECs to THP-1 Monocytes in Hyperlipidemic Conditions through PPARα/HO-1-Mediated Attenuation of Inflammation
    Wonjun Cho, Heeseung Oh, Sung Woo Choi, A.M. Abd El‐Aty, Fatma Yeşilyurt, Ji Hoon Jeong, Tae Woo Jung · 2023 · Inflammation
  42. Microparticles Carrying Peroxisome Proliferator-Activated Receptor Alpha Restore the Reduced Differentiation and Functionality of Bone Marrow-Derived Cells Induced by High-Fat Diet
    Luisa Vergori, Émilie Lauret, Raffaella Soleti, Ramaroson Andriantsitohaina, Maria Carmen Martínez · 2017 · Stem Cells Translational Medicine
  43. Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice
    Xuanmao Jiao, Lifeng Tian, Zhao Zhang, Joanna Balcerek, Andrew V. Kossenkov, Mathew Craig Casimiro, Chenguang Wang, Yichuan Liu, Adam Ertel, Raymond E. Soccio et al. · 2021 · Cancers
  44. RXR Agonists Enhance Lenalidomide Anti-Myeloma Activity and T Cell Functions while Retaining Glucose-Lowering Effect
    Jian Wu, Xiaobei Wang, Min Zhang, Parker Mathews, Yubin Kang · 2023 · Cells
  45. PPARγ acetylation governs mammary adenocarcinoma tumor growth via acetylated residues that determine DNA sequence-specific binding
    Lifeng Tian, Xuanmao Jiao, Chenguang Wang, Danni Li, Adam Ertel, Joanna Achinger-Kawecka, Sankar Addya, Raymond E. Soccio, Eric R. Chen, Balázs Győrffy et al. · 2025 · Oncogene
  46. Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) in Keratinocytes by Endogenous Fatty Acids
    Bokai Zhu, Xiaoyang Zhu, Michael G. Borland, Douglas Ralph, Christopher R. Chiaro, Kristopher W. Krausz, James Mukasa Ntambi, Adam B. Glick, Andrew D. Patterson, Gary H. Perdew et al. · 2024 · Biomolecules
  47. Effects of eicosapentaneoic acid on innate immune responses in an Atlantic salmon kidney cell line in vitro
    Tor Gjøen, Bente Ruyter, Tone-Kari Knutsdatter Østbye · 2024 · PLoS ONE
  48. Macakurzin C Derivatives as a Novel Pharmacophore for Pan-Peroxisome Proliferator-Activated Receptor Modulator
    Hyejin Ko, Seungchan An, Hongjun Jang, Sungjin Ahn, In Guk Park, Seok Young Hwang, Junpyo Gong, Soyeon Oh, Soo Yeon Kwak, Won Jun Choi et al. · 2022 · Biomolecules & Therapeutics
  49. Application of Machine Learning Methods for the Development of Antidiabetic Drugs
    Juanjuan Zhao, Pengcheng Xu, Xiujuan Liu, Xiaobo Ji, Minjie Li, Dev Sooranna, Xiaosheng Qu, Wencong Lu, Bing Niu · 2021 · Current Pharmaceutical Design
  50. Lipids and Their Role in Aging and Neurodegenerative Decline
    J. Bora, Smita Lata, Sagar Mondal, Swati Priya, Dinusha Thazhathu Veettil, Sumira Malik, Perinthottathil Sreejith · 2026 · Lipidology
  51. Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity
    Yi‐Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee, Siow‐Wey Hee, Chi‐Fon Chang, Hsin‐Yung Yen, Yi-An Chen, Yet‐Ran Chen, Ya-Wen Chou, Fu‐An Li et al. · 2025 · EMBO Molecular Medicine
  52. Hepatocytes functionally reprogrammed by KIAA1199-high colorectal cancer cells favour the accumulation of pro-metastatic Egr1+ neutrophils
    Lei Li, Lei Zhao, Kui Cao, Peiyi Zhang, Guojie Xu, Jinge Zheng, Zhenyu Lin, Dandan Yu, Jinghua Ren, Jing Zhang et al. · 2026 · Nature Communications
  53. Thymopentin improves the survival of septic mice by promoting the production of 15‐deoxy‐prostaglandin J2 and activating the PPARγ signaling pathway
    Ye Zhang, Xue Yang, Wenchao Yan, Rui Li, Qian Ye, Linjun You, Wenhao Xie, Kun Mo, Ruifeng Fu, Yanxiang Wang et al. · 2020 · The FASEB Journal
  54. Metabolic‐Associated Steatotic Liver Disease: From Molecular Mechanisms to Novel Therapies
    John Cooper, Parth Patel, Joven Tristeza, Alexander Yang · 2025 · International Journal of Hepatology
  55. Fatty acid metabolism—an emerging regulatory node in T‐cell immunometabolism
    Brett C. Arenberg, Michael N. Sack, Jing Wu · 2026 · Clinical & Translational Immunology
  56. Metabolic Reprogramming and Immune Metabolism in Sepsis: Targeting the PPAR Pathway for Personalized Therapeutic Approaches
    Zheqian Wu, Yisheng Chen, Lili Yin, 朱黎明, Fei Ding, Lihua Dai · 2026 · PPAR Research
  57. Ionizing Radiation Dose Differentially Affects the Host–Microbe Relationship over Time
    Nabarun Chakraborty, Allison Violet Hoke, Ross Campbell, Gregory P. Holmes‐Hampton, Vidya Prasanna Kumar, Candace Moyler, Aarti Gautam, Rasha Hammamieh, Sanchita Purohit Ghosh · 2024 · Microorganisms
  58. Unveiling the medicinal diversity of benzoic acid containing molecules: Insights on druggable targets for type 2 diabetes mellitus
    Kajal Rani, Preety Kumari, Anita Kumari, Debarshi Mondal, Priya Bisht, Rupali Kohal, Vivek Asati, Ghanshyam Das Gupta, Sant Kumar Verma · 2025 · Bioorganic & Medicinal Chemistry
  59. Peptide Helix-Y12 as Potential Effector for Peroxisome Proliferator-Activated Receptors
    Mauricio Carrillo‐Tripp, Yair Reyes, Blanca Delgado‐Coello, Jaime Mas‐Oliva, Roxana Gutiérrez‐Vidal · 2023 · PPAR Research
  60. Metabolic Reprogramming of Anti-cancer T Cells: Targeting AMPK and PPAR to Optimize Cancer Immunotherapy
    Abduldaheem Turki Jalil, Hassan Hadi Al-Kazzaz, Firas Hassan, Safaa Halool Mohammed, Muna Salih Merza, Tahani Aslandook, Ahmed Elewadi, Ali A. Fadhil, Ali Alsalamy · 2024 · Indian Journal of Clinical Biochemistry
  61. A Multiplex Molecular Cell-Based Sensor to Detect Ligands of PPARs: An Optimized Tool for Drug Discovery in Cyanobacteria
    Inês Páscoa, Rita Biltes, João Sousa, Marco Preto, Vitor Manuel Vasconcelos, L. Filipe C. Castro, Raquel Ruivo, Isabel Cunha · 2023 · Sensors
  62. A Novel Partial PPARα /γ Dual Agonist SN159 Improves Insulin Sensitivity
    Yujung Jung, Yongkai Cao, Suresh Paudel, Ki Hyun Kim, Goo Yoon, Seung Hoon Cheon, Jee‐Young Lee, Su‐Nam Kim, Yong Kee Kim · 2016 · Bulletin of the Korean Chemical Society
  63. Classification and regulatory interactions of key transcription factors in COVID-19
    Ndimo Modipane, Saidon Mbambara, Thato Serite, Mike Machaba Sathekge, Mankgopo Kgatle · 2025 · Frontiers in Cellular and Infection Microbiology
  64. The Nuclear Receptor Nurr1 Modulates the Expression and Activity of PPARγ in Human Pro‐Inflammatory Macrophages
    Eduardo Santana‐Cisneros, Miguel A. Solís‐Barbosa, Norma Cristina Segovia-Gamboa, Marco Antonio Meraz‐Ríos, Erika González‐Domínguez, Rosaura Hernández‐Rivas, Daniel Marrero–Rodríguez, Carmen Sánchez‐Torres · 2025 · Scandinavian Journal of Immunology
  65. Oxylipin Responses during the Yukon Arctic Ultra: The Longest and Coldest Ultramarathon in the World
    Robert H. Coker, Tadataka Tsuji, R. Lucas Thomas, Melynda S. Coker, Juan J. Aristizabal‐Henao, Michael A. Kiebish, Camilla Kienest, Adriane Schalt, Yu‐Hua Tseng, Mathias Steinach · 2025 · Military Medicine
  66. Structure-based virtual screening of plant-derived natural compounds as potential PPARα agonists for the treatment of dyslipidemia
    Phuong Thuy Viet Nguyen, Truong Le Quang Vo, Thao Anh Nguyen, Phuong Ngoc Khanh Ho, Bao Hoang Gia Nguyen · 2021 · Y HOC TP HO CHI MINH
  67. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, attenuates molecular pathological alterations in learning memory in AD mice
    Ying Li, Yanan Zhang, Qing Wang, Chuang Kuo Wu, Guicheng Du, Ying Zeng, Zhengmao Song, Xing Jiang, Xun Jiang, Rengong Zhuo et al. · 2024 · Neurological Research
  68. Conservation of the Nuclear Receptor Response Element in HIV-1 LTRs: A Possible PPAR Response Element?
    Tara Patricia Hurst · 2013 · ISRN Virology
  69. Protein–Metabolite Interactions Shape Cellular Metabolism and Physiology
    Prathibha Muralidhara, Jennifer Christina Ewald · 2022 · Methods in molecular biology
  70. Mechanism of Tetrandrine in Ameliorating Hypoxic Pulmonary Hypertension Vascular Remodeling through Transcriptomics and Metabolomics
    Xiaowei Gong, Feitian Min, Junli Guo, Ziping Zhang, Xin Liu, Wei Guo, Yaguang Wu, Hanzhou Li, Xixing Fang, Yadong Yuan et al. · 2025 · Current Drug Metabolism
  71. In Silico Integrated Systems Biology Analysis of Gut-Derived Metabolites from Philippine Medicinal Plants Against Atopic Dermatitis
    Legie Mae Soriano, Kumju Youn, Mira Jun · 2025 · International Journal of Molecular Sciences
  72. Phytochemicals and PPAR activation: Unlocking natural solutions for neurodegenerative diseases
    Saksham Naik, Sahil Verma, Sachin Thakur, Saghun Kumar, Sakshi Thakur, Ankush Kumar, Supriya Sharma · 2026 · Pharmacological Research - Natural Products
  73. Inflammation, Hormones, and Metabolism
    Muska Khpal, Mervyn Singer · 2017 · Wiley-VCH eBooks
  74. Diet and inflammation : the role of nitrate and conjugated linoleic acid
    Cecilia Jädert · 2014 · Figshare
  75. Caracterização estrutural dos complexos entre os receptores ativadores da proliferação de peroxissomos (PPARs) dos tipos alfa e gama e seus agonistas
    Jademilson C. Santos · 2014 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  76. Estudos estruturais e funcionais dos receptores ativadores da proliferação de peroxissomos
    Amanda Bernardes Muniz · 2013
  77. THE ROLE OF NITRATE AND CONJUGATED LINOLEIC ACID
    Cecilia Jädert · 2014
  78. Tratamento com metformina restaurou danos metabólicos causados pela obesidade, mas induziu a resposta inflamatória hepática.
    Alexandre Abílio de Souza Teixeira · 2015
  79. Tratamento com metformina restaurou danos metabólicos causados pela obesidade, mas induziu a resposta inflamatória hepática
    São Paulo · 2015
  80. Identifying Changes in Punitive Transcriptional Factor Binding Sites Created by PPARα/δ/γ SNPs Associated with Disease
    Norman E. Buroker · 2017 · Journal of Biosciences and Medicines
  81. 15-Deoxi-∆12,14-prostaglandina J2 (15d-PGJ2) reduz a produção de IL-8 induzida por alérgenos do ácaro Dermatophagoides pteronyssinus em linhagem de queratinócitos humanos
    Hellen Dayane Silva Borges · 2017
  82. Estudos estruturais de novos ligantes sintéticos do receptor PPARY
    Karina de Paula · 2018
  83. Improving Glucocorticoid Therapy in Chronic Lymphocytic Leukemia
    Stephanie Tung · 2013 · TSpace (University of Toronto)
  84. Elucidating the Role of Peroxisome Proliferator-activated Receptor (PPAR-δ) in Microglia Cell Function during Experimental Autoimmune Encephalomyelitis (EAE)
    Ellinore R. Doroshenko · 2019 · TSpace (University of Toronto)
  85. Identifying Therapeutic Strategies in IgA Nephropathy through Comprehensive Transcriptomic Characterization
    Kenneth Ofori, Amin Yakubu, Alex J. Rai · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for a Common Damage Mechanism of Steatohepatitis
    Peter Michael Abuja, Kurt Zatloukal, Helmut Denk · 2021 · International Journal of Molecular Sciences
  87. Efeito anti-hiperalgésico de agonistas de receptores PPAR gama em diferentes modelos de hiperalgesia em roedores
    Diogo Francisco da Silva dos Santos · 2017
  88. Ketogenic Diet and PPARγ
    Timothy A. Simeone · 2022
  89. Data from Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis
    Antonin Marchais, Maria Eugénia Marques Da Costa, Bastien Job, Rachid Abbas, Damien Drubay, Sophie Piperno-Neumann, Olivia Fromigué, Anne Gomez‐Brouchet, Françoise Rédiní, Robin Droit et al. · 2023
  90. Identification of PPAR β/δ agonists using a drug-repurposing approach by computational HTVS and molecular docking/ dynamics simulation
    Sumit Mandal, Mohammed Muzaffar-Ur-Rehman, Sonakshi Puri, Banoth Karan Kumar, Pankaj Kumar Sharma, Sankaranarayanan Murugesan, Perinkulam Ravi Deepa · 2023 · Research Square
  91. Metabolic, Neurotoxic and Immunotoxic Effects of Pfaas and Their Mixtures on the Proteome of the Head Kidney and Plasma from Rainbow Trout
    Denina Bobbie Dawn Simmons, Simon Pollard, Amila O. De Silva · 2023 · SSRN Electronic Journal
  92. Comparative Molecular Simulation of Pparg Protein Interactions with Omega-3 and Omega-6 Lipid Mediators
    Fernando Silva, Vinícius Schmitz Nunes, Roberto Faria, ODONIRIO JUNIOR · 2024 · SSRN Electronic Journal
  93. Qing-Luo-Yin-induced SIRT1 inhibition contributes to the immune improvement of adjuvant-induced arthritis rats
    Dandan Wang, Meng-Ke Song, Qin Yin, Wen-Gang Chen, Opeyemi Joshua Olatunji, Kui Yang, Jian Zuo · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Regulation of Lipid Homeostasis, Inflammatory Signalling and Atherosclerosis by the Peroxisome Proliferator-Activated Receptor Delta
    Lazar A. Bojic · 2013 · Scholarship@Western (Western University)
  95. Identification of PTGR2 inhibitors as a new therapy for diabetes and obesity
    Yi‐Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee, Siow-Wey Hee, Chi-Fon Chang, Hsin‐Yung Yen, Yi-An Chen, Yet-Ran Chen, Ya-Wen Chou, Fuan Li et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Protective role of aqueous Coriandrum sativum seed extract in diet-induced glucolipid metabolic disorder through gut–liver axis regulation
    Yan Xu, Ying Cao, Linen Zou, Wulanna, Xia Liu, Shutong Yan, Chengyi Liu, Mengran Gao, Jiuyu Zhan, Qingchun Wang et al. · 2026 · Frontiers in Endocrinology
  97. Congener-resolved hazard identification of ginkgolic acids as emerging natural contaminants
    Jie Bai, Haoyang Li, Ming Zhao, Xiaohong Yan, Liwei Hua, Min Zhang, Chen Hongming, Kaixin Zhou, Yijin Liu · 2026 · Journal of Hazardous Materials
  98. «Obesogenic memory» as a neurobiological mechanism predicting the recurrent course of obesity
    MV Shestakova, K. E. Zakharova, I. M. Yurchenkova · 2026 · Obesity and metabolism
  99. Exploring the potential mechanisms of PFDoA-induced microglial pyroptosis using cell biology experiments, network toxicology and molecular docking
    Kai-Yi Zhong, Yong Zhang, Naidong Wang, Guang-Wen Li, Xianjun Zhang, Zhijun Yang · 2026 · Food Bioscience
  100. Dietary Citrus Peel Supplementation Enhances Hepatic Energy Metabolism, Muscle 9-HODE Generation and Isoleucine Catabolism in Beef Cattle
    Susumu Muroya, Koichi Ojima, Arata Banno, Hirotaka Nagai, Kazumasa Kakibuchi, Takuma Higuchi, Shuji Sakamoto, Kazutsugu Matsukawa · 2026 · Metabolites